瘤性NOVA1表达失调乳腺癌的替代拼接
Daniel F Moakley1,2, Chaolin Zhang1,2
1Department of Systems Biology, Columbia University, New York, NY 10032, USA.
bioRxiv : the preprint server for biology
|July 19, 2024
概括
神经瘤室内抗原1 (NOVA1) 在乳腺癌中驱动神经元类拼接,特别是Luminal A瘤. 高NOVA1表达与更差的预后相关,表明潜在的致癌作用.
科学领域:
- 分子生物学分子生物学
- 在瘤学瘤学.
- 神经科学是一个神经科学.
背景情况:
- 神经瘤室内抗原1 (NOVA1) 已知用于神经元替代拼接 (AS),但最初被确定为瘤抗原.
- 人们还在讨论NOVA1在癌症中的作用,其潜在的瘤抑制和瘤致癌功能.
- 它在乳腺癌中对AS的参与仍然不清楚.
研究的目的:
- 研究NOVA1在乳腺侵袭性癌症 (BRCA) 中替代拼接中介作用.
- 确定NOVA1表达对拼接模式和瘤特征的影响.
- 评估NOVA1介导AS在不同乳腺癌亚型的预后意义.
主要方法:
- 对乳腺侵入性癌 (BRCA) 瘤样本中的替代拼接配置文件的分析.
- 在异胎 NOVA1 表达时检查基因表达和拼接变化.
- 对NOVA1表达水平,拼接模式和患者预后之间的相关性分析.
主要成果:
- 异位NOVA1表达诱导了BRCA中类似神经元的拼接模式,影响细胞外围和细胞骨架基因.
- 由NOVA1引起的拼接失调在Luminal A乳腺瘤中最为突出.
- 在Luminal A瘤中高NOVA1表达与患者预后明显差相关.
结论:
- 乳腺瘤中的异位NOVA1表现出调控活性,影响瘤进展至关重要的途径.
- 通过NOVA1介导的替代拼接可能是神经瘤神经障碍抗原的一般机制.
- 这些发现凸显了NOVA1在特定乳腺癌亚型中的潜在瘤作用.
相关概念视频
RNA Splicing
56.3K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.3K
Alternative RNA Splicing
21.1K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
21.1K
Cancer-Critical Genes I: Proto-oncogenes
8.8K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.8K
Loss of Tumor Suppressor Gene Functions
4.8K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.8K
Cancers Originate from Somatic Mutations in a Single Cell
11.9K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.9K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K


